Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Antiretroviral Therapy News
New Single-pill Combo Effective Against HIV-1A new fixed-dose combination of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is noninferior to fixed-dose efavirenz/emtricitabine/TDF (EFV/FTC/TDF) in treatment-naive adults with HIV-1 infection, according to results from the DRIVE-AHEAD trial.
Reuters Health Information, September 19, 2018
HIV Prevention Pill Reaching More People Who Need ItMore than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.
What Doravirine Offers Patients With HIVDr Paul Sax describes the trials that led to the approval of doravirine, which might offer some benefits to patients who can't tolerate other NNRTIs.
Medscape HIV/AIDS, September 13, 2018
USCA 2018Read clinically focused news coverage of key developments from UCSA 2018.
